Medicine

N. Pu, W. Lou, Jun Yu

2019.3.1Journal of Pancreatology

DOI: 10.1097/jp9.0000000000000010

tlooto Summary

Pancreatic ductal adenocarcinoma is the known kind of tumor biologically featured as high malignant degree, lack of effective methods for diagnosis and treatment, which reflects its unpleasant prognosis.

Abstract

AbstractPancreatic ductal adenocarcinoma is the known kind of tumor biologically featured as high malignant degree, lack of effective methods for diagnosis and treatment, which reflects its unpleasant prognosis. Recently, with the breakthrough of burgeoning therapeutic methods, the flush of dawn for

Citation format

PU, N.; LOU, W.; YU, Jun. PD-1 immunotherapy in pancreatic cancer: Current status. Journal of Pancreatology, 2019.